Correlation Between Pfizer and Energy Revenue

Can any of the company-specific risk be diversified away by investing in both Pfizer and Energy Revenue at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Energy Revenue into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and Energy Revenue Amer, you can compare the effects of market volatilities on Pfizer and Energy Revenue and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Energy Revenue. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Energy Revenue.

Diversification Opportunities for Pfizer and Energy Revenue

-0.33

Correlation Coefficient

Pfizer  Energy Revenue

Very good diversification

The 3 months correlation between Pfizer and Energy is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Energy Revenue Amer in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Energy Revenue Amer and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Energy Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Energy Revenue Amer has no effect on the direction of Pfizer i.e., Pfizer and Energy Revenue go up and down completely randomly.

Pair Corralation between Pfizer and Energy Revenue

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Energy Revenue. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 35.22 times less risky than Energy Revenue. The stock trades about -0.05 of its potential returns per unit of risk. The Energy Revenue Amer is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  5.20  in Energy Revenue Amer on December 28, 2024 and sell it today you would earn a total of  2.79  from holding Energy Revenue Amer or generate 53.65% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.36%
Values	Daily Returns

Pfizer Inc  vs.  Energy Revenue Amer

Pfizer Inc

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Energy Revenue Amer

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Energy Revenue Amer are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Energy Revenue displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pfizer and Energy Revenue

The main advantage of trading using opposite Pfizer and Energy Revenue positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Energy Revenue can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Energy Revenue will offset losses from the drop in Energy Revenue's long position.

The idea behind Pfizer Inc and Energy Revenue Amer pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.